勝利精密(002426.SZ):涉及重大資產重組的股轉協議已基本定稿
格隆匯2月26日丨勝利精密(002426.SZ)公佈,公司於2019年5月11日發佈了《關於擬籌劃重大資產重組暨關聯交易的提示性公告》,公司擬將全資子公司南京德樂科技有限公司(“南京德樂”)100%股權出售給南京德樂商業管理有限公司和南京星月商業管理合夥企業(有限合夥),此次交易可能構成重大資產重組和關聯交易。
截至公告日,股轉協議已基本定稿,但受疫情等因素影響中介機構的核查事項尚未完成,公司將盡快推進各項工作。鑑於本次重大資產重組事項尚需履行相關決策和審批程序,存在一定的不確定性,為維護投資者利益,公司將根據重大資產重組的進展情況,及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.